Gene therapy for Crigler-Najjar syndrome: First patient treated in the European clinical trial sponsored by Genethon

Following patient recruitment and a preliminary observation period, the first patient was injected by Prof. Labrune at Beclere Hospital in Clamart, France. Genethon, the coordinator of the CureCN project, has published the following press release.